Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Why Millennials Should Aim For $4 Million For Retirement
02:30pm, Saturday, 26'th Nov 2022 Seeking Alpha
We discuss how young folks in their early 30s can aim and accumulate a large sum by the time they are in their 50s. See how big can be your retirement savings.
Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations
03:22pm, Thursday, 24'th Nov 2022 Zacks Investment Research
Mirati Therapeutics' (MRTX) new drug application (NDA), seeking approval for adagrasib, its KRAS inhibitor drug, for previously-treated KRASG12C-mutated NSCLC is under review with the FDA with a decis
AMGEN ANNOUNCES WEBCAST OF 2022 EVERCORE ISI HEALTHCARE CONFERENCE
04:00pm, Wednesday, 23'rd Nov 2022
THOUSAND OAKS, Calif. , Nov. 23, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 11:20 a.m.
Buy this Medical Sector Pioneer Stock
04:53pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.
Buy this Medical Sector Pioneer Stock
01:33pm, Tuesday, 22'nd Nov 2022
Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.
Should You Invest in the VanEck Biotech ETF (BBH)?
11:20am, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Sector ETF report for BBH
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
02:00pm, Monday, 21'st Nov 2022 Zacks Investment Research
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Take the Zacks Approach to Beat the Market: Axon, Rollins, Starbucks in Focus
12:22pm, Monday, 21'st Nov 2022 Zacks Investment Research
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:32am, Monday, 21'st Nov 2022
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Where Amgen Stands With Analysts
08:02pm, Friday, 18'th Nov 2022 Benzinga
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
2
0
Last 30D
0
0
0
Credit Suisse Sets Bearish Tone For Amgen; Says Current Setup Not Ideal For Growth
07:50pm, Friday, 18'th Nov 2022 Benzinga
Credit Suisse has initiated coverage on Amgen Inc (NYSE: AMGN) with an Underperform rating and a price target of $240.
The analysts say that Amgen has had a solid year, with the stock up c.25% yea
CytomX (CTMX) Stock Surges on Oncology Deal With Regeneron
06:18pm, Friday, 18'th Nov 2022 Zacks Investment Research
CytomX (CTMX) gets a boost after its deal with Regeneron for the development of investigational next-generation bispecific immunotherapies.
What 7 Analyst Ratings Have To Say About Amgen
05:02pm, Friday, 18'th Nov 2022 Benzinga
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
2
0
Last 30D
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
04:58pm, Friday, 18'th Nov 2022 Benzinga
Upgrades
According to Summit Insights Group, the prior rating for Applied Materials Inc (NASDAQ:AMAT) was changed from Hold to Buy. For the fourth quarter, Applied Materials had an EPS of $2.03, comp
Analyst Ratings for Amgen
04:01pm, Friday, 18'th Nov 2022 Benzinga
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
3
2
2
0
Last 30D
0
0
0
